Ispire Technology Inc.
Business
Ispire Technology Inc. is engaged in the research, development, design, commercialization, sales, marketing and distribution of branded and non‑branded vaping hardware products for nicotine and cannabis markets. Its main products include e‑cigarette systems (open and closed), cartridges, batteries, coils and tanks, and cannabis vaporizer hardware incorporating technologies such as DuCore™, BVC, BDC, Cleito, Ispire ONE™ and G‑Mesh. Key operating units include Aspire North America and Aspire Science, OEM/ODM manufacturing operations and the IKE age‑gating joint venture. The company sells globally through an extensive distributor network, direct ODM sales to cannabis brands, and regionally in Europe, Asia Pacific, North America and other international markets.
Summary from filing dated 2025-09-15
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 |
|---|---|---|---|---|---|
| Revenue | 127 | 152 | 116 | 88 | |
| Cost of revenue | 105 | 122 | 95 | 75 | |
| Gross profit | 23 | 30 | 21 | 13 | |
| Sales and marketing expenses | 8 | 7 | 4 | 6 | |
| Credit loss expenses | 22 | 6 | — | — | |
| General and administrative expenses | 30 | 31 | 21 | 9 | |
| Total operating expenses | 60 | 44 | 25 | 14 | |
| Loss from operations | −38 | −14 | −4 | −988,671 | |
| Interest income, net | 86,996 | 365,251 | — | — | |
| Exchange loss, net | −86,570 | −70,293 | −324,225 | 58,143 | |
| Other (expense) income, net | −187,089 | 113,405 | −155,150 | 185,615 | |
| Total other (expense) income, net | −186,663 | 408,363 | −284,166 | — | |
| Loss before income taxes | −38 | −13 | −5 | −803,056 | |
| Income taxes current | −1 | −1 | −1 | — | |
| Net loss | −39 | −15 | −6 | −2 | |
| Foreign currency translation adjustments | −167,214 | 222,111 | 20,896 | −117,085 | |
| Comprehensive loss | −39 | −15 | −6 | −2 | |
| Basic (in Dollars per share) | −0.69 | −0.27 | −0.12 | −0.04 | |
| Diluted (in Dollars per share) | −0.69 | −0.27 | −0.12 | −0.04 | |
| Basic (in Shares) | 57 | 55 | 51 | 50 | |
| Diluted (in Shares) | 57 | 55 | 51 | 50 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2024 2024-03-31 | FY 2023 2023-12-31 | FY 2023 2023-09-30 |
|---|---|---|---|---|---|---|
| Cash | 24 | 35 | — | — | — | |
| Accounts receivable, net | 40 | 60 | — | — | — | |
| Inventories, net | 7 | 6 | — | — | — | |
| Prepaid expenses and other current assets | 2 | 1 | — | — | — | |
| Total current assets | 73 | 103 | — | — | — | |
| Accounts receivable non current | 7 | — | — | — | — | |
| Property, plant and equipment, net | 3 | 3 | — | — | — | |
| Intangible assets, net | 2 | 1 | — | — | — | |
| Right-of-use assets operating leases | 5 | 4 | 4 | 4 | 5 | |
| Other investment | 2 | 2 | — | — | — | |
| Equity method investment | 10 | 10 | — | — | — | |
| Other non-current assets | 210,617 | 284,050 | 297,474 | 299,261 | 170,562 | |
| Total other assets | 29 | 20 | 9 | 7 | 7 | |
| Total assets | 102 | 123 | 108 | 90 | 88 | |
| Accounts payable | 4 | 4 | — | — | — | |
| Contract liabilities | 5 | 2 | — | — | — | |
| Accrued liabilities and other payables | 8 | 12 | — | — | — | |
| Borrowing current portion | 1 | — | — | — | — | |
| Operating lease liabilities current portion | 2 | 1 | 1 | 1 | 1 | |
| Total current liabilities | 73 | 86 | 70 | 58 | 54 | |
| Borrowing net of current portion | 805,361 | — | — | — | — | |
| Operating lease liabilities net of current portion | 3 | 2 | — | — | — | |
| Total liabilities | 102 | 88 | 72 | 61 | 57 | |
| Commitments and contingencies | — | — | — | — | — | |
| Common stock, par value $0.0001 per share; 140,000,000 shares authorized; 57,193,734 and 56,470,636 shares issued and outstanding as of June 30, 2025 and June 30, 2024 | 5,719 | 5,647 | — | — | — | |
| Treasury stock, at cost | −60,488 | — | — | — | — | |
| Additional paid-in capital | 49 | 43 | — | — | — | |
| Accumulated deficit | −48 | −9 | −5 | 609,283 | 5 | |
| Accumulated other comprehensive (loss)/income | −108,871 | 58,343 | — | — | — | |
| Total stockholders equity | 604,694 | 34 | 36 | 29 | 31 | |
| Total liabilities and stockholders equity | 102 | 123 | 108 | 90 | 88 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 |
|---|---|---|---|---|---|
| Depreciation and amortization | 812,483 | 505,653 | 46,662 | — | |
| Right-of-use assets amortization | 1 | 1 | 1 | — | |
| Stock-based compensation expenses | 6 | 6 | — | — | |
| Inventory impairment | 754,976 | 205,594 | — | — | |
| Loss from equity method investment | 732,502 | 117,905 | — | — | |
| Right-of-use assets impairment | 151,516 | — | 1 | 135,141 | |
| Debt issuance cost amortization | 38,478 | — | — | — | |
| Accounts receivable | −9 | −41 | −20 | −4 | |
| Inventories | −1 | 901,120 | 7 | −12 | |
| Prepaid expenses and other current assets | −547,085 | 2 | −3 | 29,007 | |
| Accounts payable and accounts payable related party | 11 | 18 | 11 | 9 | |
| Contract liabilities | 3 | 1 | −690,637 | — | |
| Accrued liabilities and other payables | −555,383 | 2 | 168,179 | — | |
| Operating lease liabilities | −1 | −1 | −1 | — | |
| Prepaid income tax/income tax payable | −315,189 | −63,853 | −417,260 | 481,113 | |
| Net cash used in operating activities | −7 | −18 | −8 | −8 | |
| Purchase of property, plant and equipment | −1 | −2 | −1 | −121,516 | |
| Acquisition of intangible assets | −939,075 | −1 | — | — | |
| Maturity of short term investment | — | 9 | — | — | |
| Acquisition of other investment | — | −2 | — | — | |
| Acquisition of equity method investment | — | −1 | — | — | |
| Repayment of acquisition payable | −3 | — | — | — | |
| Net cash (used in) provided by investing activities | −5 | 3 | −10 | −121,516 | |
| Common stock repurchased | −60,488 | — | — | — | |
| Proceeds from equity offerings | — | 12 | — | — | |
| Issuance costs of equity offerings | — | −2 | — | — | |
| Proceeds from borrowing | 2 | — | — | — | |
| Repayment of borrowing | −167,214 | — | — | — | |
| Repayments of advances from a related party | — | −703,323 | −38 | −2 | |
| Net cash provided by financing activities | 2 | 10 | −16 | −3 | |
| Net decrease in cash | −11 | −5 | −34 | — | |
| Leased assets obtained in exchange for operating lease liabilities | 3 | 537,307 | — | — | |
| Reclassification of accounts receivable to accounts receivable non current | 7 | — | — | — | |
| Reclassification of accounts payable related party to amount due to a related party | 25 | — | — | — | |
| Unpaid equity method investment in accrued liabilities and other payables | — | 9 | — | — | |
| Warrants issued in connection with equity method investment | — | 365,953 | — | — | |
| Unpaid intangible assets in accrued liabilities and other payables | — | 232,382 | — | — | |
| Cash paid for income taxes | 2 | 1 | — | — | |
| Cash paid for interest | 150,285 | 15,229 | 587 | — |